While implant shells themselves do not directly stimulate tumor growth, they may act as passive carriers for bacteria, with biofilm-derived lipopolysaccharide (LPS) interacting with TLR4 to promote inflammatory cytokine release and tumor progression [55]. Here, TLR4 is linked to neoplasm.